IL2 and neoplasm: We found significant enrichment of immune-related signaling pathways in most tumor types, including TNFA-signaling-via-NFκB, IFN- γ response, IFN- α response, inflammatory response, IL6-JAK-STAT3, IL2-STAT5, and allograft-rejection.